Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.
Clinical trial NCT04881045 · COMPLETED
Trial details
- NCT number
- NCT04881045
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2023-10-24
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.